These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23412044)

  • 1. [Vaccination against human papilloma virus: a Chilean experience at primary health care centers].
    Real W; Alvarado V
    Rev Chilena Infectol; 2012 Dec; 29(6):686. PubMed ID: 23412044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papilloma vaccination to adolescents.
    Levavi H
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):2-5. PubMed ID: 21037538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-preventive care: challenges and opportunities for adolescent HPV vaccination.
    Vadaparampil ST; Perkins R
    Hum Vaccin Immunother; 2014; 10(9):2557-8. PubMed ID: 25483473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey.
    Tan J; Farrell L; Allen DG
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):472-7. PubMed ID: 21039383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
    Abarca V K; Valenzuela B MT; Vergara F R; Luchsinger F V; Muñoz M A; Jiménez de la Jara J; Ripoll M E; O'Ryan G M
    Rev Chilena Infectol; 2008 Dec; 25(6):428-34. PubMed ID: 19194605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.
    Guerry SL; De Rosa CJ; Markowitz LE; Walker S; Liddon N; Kerndt PR; Gottlieb SL
    Vaccine; 2011 Mar; 29(12):2235-41. PubMed ID: 21288799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The first HPV vaccine is now available].
    Kjaer SK; Olesen F; Toftager-Larsen K; Sand C; Strauss GI; Hoffmann TU; Ottesen BS
    Ugeskr Laeger; 2006 Oct; 168(44):3827-8. PubMed ID: 17118245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
    Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
    Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers prevent HPV vaccination in low-income populations.
    AIDS Patient Care STDS; 2010 Jan; 24(1):70. PubMed ID: 20169639
    [No Abstract]   [Full Text] [Related]  

  • 13. Human papillomavirus infection among young adolescents in India: impact of vaccination.
    Hussain S; Bharadwaj M; Nasare V; Kumari M; Sharma S; Hedau S; Das BC
    J Med Virol; 2012 Feb; 84(2):298-305. PubMed ID: 22170551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of human papilloma virus vaccination in Iceland.
    Oddsson K; Johannsson J; Asgeirsdottir TL; Gudnason T
    Acta Obstet Gynecol Scand; 2009; 88(12):1411-6. PubMed ID: 19900074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
    Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
    J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland.
    Woodhall SC; Lehtinen M; Verho T; Huhtala H; Hokkanen M; Kosunen E
    J Adolesc Health; 2007 May; 40(5):466-9. PubMed ID: 17448408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
    Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
    Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch.
    Henninger J
    J Prim Health Care; 2009 Dec; 1(4):278-85. PubMed ID: 20690336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US falls short of target for vaccinating adolescents against HPV.
    McCarthy M
    BMJ; 2014 Jul; 349():g4877. PubMed ID: 25069751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.